Virology
Mutation protects from HIV but increases risk of hepatitis C
Published in Hepatitis Weekly, August 12th, 2002
Yet some people are resistant to infection: the reason for this is a mutation in their DNA that prevents HIV from invading certain immune cells and destroying them. Bonn, Germany scientists have now discovered, however, that this resistance to HIV increases the probability of a persistent infection with hepatitis C, a disease that can also be fatal. The findings recently published in the journal Gastroenterology may influence possible therapeutic strategies for tackling HIV infections.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2002-08-12)
More Articles from Hepatitis Weekly
- Chronic Hepatitis C
Young livers provide transplant recipients with graft survival advantage - Nosocomial Infections
Diabetes patients in Poland at risk for hepatitis B virus, need vaccinations - Chronic Hepatitis B
Doctors inclined to test for cancer when hepatitis B core antibody present - Gene Characterizing
Search for marker leads investigators to new liver cancer gene - Hepatitis D Virus
Famciclovir not effective against chronic hepatitis delta virus - Chronic Hepatitis C
FDA grants priority review for Pegasys combination treatment of hepatitis C - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
